The Neurotoxin Institute

PTN 2 FOOTAGE

November 2004; 1 hour CME Credit

Two presentations:

Jankovic on BoNT in CD
Dolly on MOA of BoNT: Molecular Basis for the Therapeutic Effectiveness of BoNT

CD Contents:

Epidemiology
Diagnosis
Clinical features
Treatment
Standards of clinical practice
Evaluation of Patients with CD
Strive to improve response
Muscles to be treated
Long-term efficacy of BoNT
PatientTestimonial

Aesthetics Blepharospasm Cerebral Palsy Cervical Dystonia GI Disorders Headache Introduction to Movement Disorders MOA of Botulinum Toxin Muscle Pain Strabismus Upper Motor Neuron Syndrome (including Spasticity)Urologic Applications

©Neurotoxin Institute 2002-2008. Terms of Use | Disclosure
The Neurotoxin Institute Web site is reviewed by the University of South Florida College of Medicine.
The NTI is administered by 4D Communications. Powered by Asentia.